date founded
Financing round
General
About Company
Related to
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a leading company in the field of RNA-targeted therapeutics.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Panbela Therapeutics
Sun BioPharma is a drug development company focused on providing cancer patients with fast access to therapeutics.
Sector
Subsector
Location
total rounds
total raised
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops and commercializes controlled release combination therapeutics to treat healthcare problems.
Sector
Subsector
Location
total rounds
total raised
Sumitovant
Sumitovant is a biopharmaceutical company focused on developing innovative medicines and therapies for patients.
Sector
Subsector
Keywords
Location
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for cancer and other major diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Ionis Pharmaceuticals
announced date
price
Financials
Co-Investors
People
Founders1
Paula Soteropoulos
Paula Soteropoulos is the Chairman of the Board of Ensoma. She is a former Founding CEO at Akcea Therapeutics. Paula is a global strategic and operating management executive with over 20 years of success at building high-performance global teams, leading complex development programs from early stage through approval, and launching global products. Prior to joining Moderna, Paula was the Vice President and General Manager of Genzyme’s Global Cardiovascular business. She was responsible for the development and commercialization of multiple therapeutics across Renal, Transplant & Oncology, Rare Disease, and Cardiovascular. During her tenure at Genzyme, she was instrumental in advancing new compounds from discovery through clinical development and commercialization with significant roles driving product strategy, portfolio, program and alliance management, sales and marketing and business development. Additionally, Paula led strategic manufacturing capacity planning, supply chain development, and manufacturing process development. Prior to Genzyme, Paula was a bioprocess engineering consultant for various biopharmaceutical companies. She serves on the Board of Directors of uniQure B.V, a world leader in human gene therapy; the Board of Directors of JFYNet, a non-profit education organization; and the Advisory Board of the Tufts University Chemical and Biological Engineering Department. She is a member of the Healthcare Business Women’s Association and serves as a mentor. Paula earned her B.S. and M.S. in Chemical and Biochemical Engineering from Tufts University and earned an executive management certificate from Darden School of Business, University of Virginia. She is a past honoree of Mass High Tech’s Women to Watch.
current job
organization founded
Paula Soteropoulos
Employee Profiles37
Michael Price
Executive vice president and chief financial officer
Henry Zheng
Global brand director, cardiometabolic franchise